Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

AVLN US Equity

Avalyn Pharma Inc.Health Care · Pharmaceutical Preparations · CIK 1540171 · FY ends Dec 31
$38.97
+0.11 (+0.28%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Novo Holdings A/Ssec.gov ↗
2026-08-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1113GSchedule 13G filed — ≥5% beneficial owner (passive) · by Norwest Venture Partners XV, LPsec.gov ↗
2026-08-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-06

Every row is a filed document, checked against its EDGAR index.